Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Clinical Trials, Lymphomas, Workforce, Diversity, Equity, Inclusion, and Accessibility (DEI/DEIA) , Diseases, Therapies, aggressive lymphoma, Lymphoid Malignancies, Study Population
Type: Oral
Hematology Disease Topics & Pathways:
Clinical Trials, Lymphomas, Workforce, Diversity, Equity, Inclusion, and Accessibility (DEI/DEIA) , Diseases, Therapies, aggressive lymphoma, Lymphoid Malignancies, Study Population
Saturday, December 11, 2021: 4:00 PM-5:30 PM
B401-B402, Level 4, Building B
(Georgia World Congress Center)
Moderators:
Jennifer Crombie, MD, Dana Farber Cancer Institute
and
Nilanjan Ghosh, MD, PhD, Levine Cancer Institute
Disclosures:
Ghosh: Incyte: Consultancy, Honoraria; AstraZeneca: Consultancy, Honoraria, Speakers Bureau; Genmab: Consultancy, Honoraria; Genentech: Research Funding; Gilead: Consultancy, Honoraria, Research Funding, Speakers Bureau; Pharmacyclics LLC, an AbbVie Company: Consultancy, Honoraria, Research Funding, Speakers Bureau; TG Therapeutics: Consultancy, Honoraria, Research Funding; Seattle Genetics: Consultancy, Honoraria, Speakers Bureau; ADC Therapeutics: Consultancy, Honoraria; Bristol Myers Squibb: Consultancy, Honoraria, Research Funding, Speakers Bureau; Epizyme: Honoraria, Speakers Bureau; Adaptive Biotech: Consultancy, Honoraria; Janssen: Consultancy, Honoraria, Speakers Bureau; Karyopharma: Consultancy, Honoraria; AbbVie: Honoraria, Speakers Bureau.
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH